
NHK World-Japan: Developing a new way to fight cancer
International news outlet focuses on the work of Atsuo Sasaki and his cancer research
Atsuo Sasaki, associate professor in the Department of Cancer Biology at the University of Cincinnati and a researcher within the UC Cancer Center, discovered the metabolic mechanism of cells which could open up new possibilities for cancer treatments. A molecule called GTP holds the key.
Sasaki uncovered that a certain enzyme which reacted to GTP in cells acts as an "energy sensor," sending signals for cancer cells to grow. Furthermore, his recent study revealed the mechanism causing nucleolus enlargement in certain cancer cells, a mystery for more than 100 years.
Currently, he is conducting joint research involving scientists at Cincinnati Children's Hospital Medical Center and the UC James L. Winkle College of Pharmacy to uncover how his findings could be connected to metabolic diseases related to obesity.
In addition to Sasaki, Timothy Pheonix, assistant professor at the UC James L. Winkle College of Pharmacy, is featured in this news story. NHK World-Japan is a state-owned international boadcaster aimed at overseas markets and is similar to BBC World News and CNN International.
Watch the full story and learn more about UC research.
Featured photo by Colleen Kelley/UC Creative Services
Related Stories
What parvovirus is and why it's on the rise
July 10, 2025
An infectious virus common in children is on the rise in the Tristate. The Cincinnati Health Department is warning of a rise in parvovirus in Hamilton County. The illness can present itself as a rash on the cheeks and is often called “slapped cheek” disease but can present more serious concerns in pregnant women. Kara Markham, MD, professor of obstetrics and gynecology at the University of Cincinnati College of Medicine recently appeared on Cincinnati Edition on WVXU to discuss how parvovirus is transmitted, the risk of serious cases and how to prevent it.
UC joins international Phase 1 trial testing CAR-T therapy for MS
July 10, 2025
The University of Cincinnati Gardner Neuroscience Institute is a trial site for a multicenter, international Phase 1 trial testing CAR-T cell therapy for patients with multiple sclerosis.
Inflammation, not symptoms, found to disrupt sleep in IBD...
July 9, 2025
Impaired sleep architecture in inflammatory bowel disease (IBD) is primarily driven by inflammatory activity rather than symptomatic flares as previously thought, according to a study published in Clinical Gastroenterology and Hepatology. Sleep architecture is the structural organization of a normal sleep cycle, encompassing the progression and distribution of different stages of sleep throughout a typical night’s rest.